Fibromyalgia and mortality: a systematic review and meta-analysis

RMD Open. 2023 Jul;9(3):e003005. doi: 10.1136/rmdopen-2023-003005.

Abstract

Objective: To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis.

Methods: The authors searched the PubMed, Scopus, and Web of Science databases using the key words 'fibromyalgia' and 'mortality' to identify studies that addressed an association between fibromyalgia and mortality. Original papers that assessed associations between fibromyalgia and mortality (all or specific causes) and provided an effect measure (hazard ratio (HR), standardised mortality ratio (SMR), odds ratio (OR)) quantifying the relationship between fibromyalgia and mortality were included in the systematic review. Of 557 papers that were initially identified using the search words, 8 papers were considered eligible for the systematic review and meta-analysis. We used a Newcastle-Ottawa scale to assess the risk of bias in the studies.

Results: The total fibromyalgia group included 188 751 patients. An increased HR was found for all-cause mortality (HR 1.27, 95% CI 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. There was a borderline increased SMR for accidents (SMR 1.95, 95% CI 0.97 to 3.92), an increased risk for mortality from infections (SMR 1.66, 95% CI 1.15 to 2.38), and suicide (SMR 3.37, 95% CI 1.52 to 7.50), and a decreased mortality rate for cancer (SMR 0.82, 95% CI 0.69 to 0.97). The studies showed significant heterogeneity.

Conclusions: These potential associations indicate that fibromyalgia should be taken seriously, with a special focus on screening for suicidal ideation, accident prevention, and the prevention and treatment of infections.

Keywords: Fibromyalgia; Infections; Outcome Assessment, Health Care.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Databases, Factual
  • Fibromyalgia* / epidemiology
  • Humans
  • Odds Ratio